Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Spier

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Blood|January 15, 1993
P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapyT M Grogan, C M Spier, S E Salmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Diffuse small cleaved-cell lymphoma: a heterogeneous disease with distinct immunobiologic subsetsC P Leith, C M Spier, T M Grogan, et al.
Blood|April 1, 1988
Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67T M Grogan, S M Lippman, C M Spier, et al.
The New England Journal of Medicine|July 2, 1998
Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphomaT P Miller, S Dahlberg, J R Cassady, et al.
Blood|March 15, 1994
Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trialT P Miller, T M Grogan, S Dahlberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphomaD J Slymen, T P Miller, S M Lippman, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Blood|January 15, 1993
P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapyT M Grogan, C M Spier, S E Salmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Diffuse small cleaved-cell lymphoma: a heterogeneous disease with distinct immunobiologic subsetsC P Leith, C M Spier, T M Grogan, et al.
Blood|April 1, 1988
Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67T M Grogan, S M Lippman, C M Spier, et al.
The New England Journal of Medicine|July 2, 1998
Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphomaT P Miller, S Dahlberg, J R Cassady, et al.
Blood|March 15, 1994
Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trialT P Miller, T M Grogan, S Dahlberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphomaD J Slymen, T P Miller, S M Lippman, et al.
Pageof 4